Gomis
LightNews LightNews
rgergom.bsky.social
Gomis
@rgergom.bsky.social
110 followers 44 following 5 posts
Eager for science, passion for arts... opinions are my own
Posts Replies Media Videos
Reposted by Gomis
irbbarcelona.org
🧪Don't miss this webinar by Dr. @rgergom.bsky.social (#IRBBarcelona-#Inbiomotion) that explores the biology & mechanism of action of the MAF gene, shedding light on its significant impact on patient outcomes.

@sourcebioscience.bsky.social

https://youtu.be/M7bvPjPQCq0?feature=shared

#BreastCancer
Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.
youtu.be
March 12, 2025 at 10:02 AM
Reposted by Gomis
irbbarcelona.org
📌 MetEND: Descodificando las dependencias entre la #metástasis y la vasculatura.

El proyecto coordinado por el Dr. @rgergom.bsky.social pretende desarrollar nuevas opciones para el tratamiento del #CáncerdeMama metastásico, para lo que estudiará la relación entre la metástasis y la vascularización.
February 24, 2025 at 12:25 PM
Reposted by Gomis
irbbarcelona.org
💬Mesa Redonda: Presente y Futuro del #CáncerDeMama

🗣️Dr. @rgergom.bsky.social (@irbbarcelona.org) 
🗣️Dr. César Serrano (Hospital Vall d'Hebron-@vhio.bsky.social) 
🗣️Carme Segura, paciente cáncer de mama
🎙️Modera: Michele Catanzaro

🗓️Miérc, 5 de febrero
🕡 18:30-20:00h
📍@iec.cat 
🔗 https://bit.ly/3Wx0Fw5
January 30, 2025 at 10:02 AM
Reposted by Gomis
mmalumbres.bsky.social
Exciting news in cancer therapy! The order of drugs impacts the duration of treatment, toxicity, and economic cost. A necessary example of how relevant academic, self-funded trials are!!
Breast #cancer #oncosky #oncsky #medsky 🧪 @natureportfolio.bsky.social www.nature.com/articles/d41...
Toxicity and costs of cancer treatment reduced by deferring CDK4/6 inhibitor use
No difference in survival outcomes between use of CDK4/6 inhibitors as first- or second-line treatment in metastatic breast cancer.
www.nature.com
November 27, 2024 at 7:21 PM
Reposted by Gomis
irbbarcelona.org
🔵 The #IRBBarcelona Growth Control & #Cancer #Metastasis lab, led by @rgergom.bsky.social is offering two 3-year #PhD #fellowships in the framework of the Adaptmet Project for young scientists community who wish to undertake a doctoral degree in #biomedicine.

Read more here ➡️ shorturl.at/MDX95
November 26, 2024 at 11:40 AM
rgergom.bsky.social
Terrific talk by @mmalumbres.bsky.social !! at the biomed conference in barcelona
November 18, 2024 at 11:26 AM
Reposted by Gomis
mmalumbres.bsky.social
Let’s get started: BioMed Conference on “Mechanisms of resistance in cancer”. Francesc Posas, director of the IRB Barcelona, introducing the event! #oncosky 🧪
November 18, 2024 at 8:05 AM
Reposted by Gomis
mmalumbres.bsky.social
Just one day left for the #BarcelonaBiomed Conference "Molecular Determinants of #Cancer Therapy Resistance"!
🗓️ 18-20 Nov, 2024 #Barcelona

🤝 Angel R Nebreda (#IRB), Clare Isake (ICR_London) & @mmalumbres.bsky.social (VHIO), with @batllelab.bsky.social and a long list of speakers.

➡️bit.ly/4dBTSYI
November 17, 2024 at 8:19 AM
Reposted by Gomis
mmalumbres.bsky.social
Cancer cell biologists in the 2024 meeting of the Spanish Association of Cancer Research (ASEICA) in beautiful Zaragoza.. waiting for you guys here in @bsky.app
November 15, 2024 at 3:18 AM
Reposted by Gomis
mmalumbres.bsky.social
Historical alliance between Spanish associations against #cancer… ASEICA and AECC ContraCancer… we need you in @bsky.app
November 15, 2024 at 12:05 PM